Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
αTAT1 links microtubules to stiffness sensing, fibroblast activation, and fibrosis
Alba Santos, Tamanna Islam, Maria-Anna Chrysovergi, Paula E. Grasberger, Vera Auernheimer, Taslim A. Al-Hilal, Santiago Lamas, David Lagares
Alba Santos, Tamanna Islam, Maria-Anna Chrysovergi, Paula E. Grasberger, Vera Auernheimer, Taslim A. Al-Hilal, Santiago Lamas, David Lagares
View: Text | PDF
Research Article Cell biology Pulmonology

αTAT1 links microtubules to stiffness sensing, fibroblast activation, and fibrosis

  • Text
  • PDF
Abstract

Matrix stiffening sustains fibrosis by recruiting fibroblasts to stiff fibrotic areas through durotaxis. Once recruited, fibroblasts become mechanically activated and promote scar formation. Although actin-based mechanotransduction and focal adhesion signaling are well established, how microtubules contribute to stiffness sensing and fibroblast activation in fibrosis remains incompletely understood. Here, we identify αTAT1-mediated microtubule acetylation as a key regulator of fibroblast mechanosensing, durotaxis, and profibrotic activation. Through α-tubulin K40 acetylation, αTAT1 promotes microtubule flexibility, directional alignment, and persistent polarity along stiffness gradients, thereby enabling stiffness-directed migration and fibroblast activation. Mechanistically, αTAT1-dependent microtubule acetylation regulates focal adhesion dynamics and downstream mechanotransduction. αTAT1 loss abolishes K40 acetylation, impairs FAK-mediated YAP/TAZ signaling, and prevents stiffness- and TGF-β–induced myofibroblast differentiation. Accordingly, global or fibroblast-specific Atat1 depletion reduces fibroblast durotaxis and the accumulation of profibrotic fibroblasts, protecting mice from lung, dermal, and kidney fibrosis without affecting inflammation or vascular integrity. Our findings establish αTAT1-dependent microtubule acetylation as a conserved mechanosensing pathway that links fibroblast durotaxis and activation to fibrosis across organs in vivo, and identify αTAT1 catalytic activity as a potential mechano-therapeutic target in fibrotic disease.

Authors

Alba Santos, Tamanna Islam, Maria-Anna Chrysovergi, Paula E. Grasberger, Vera Auernheimer, Taslim A. Al-Hilal, Santiago Lamas, David Lagares

×

Figure 3

αTAT1 deficiency protects mice from bleomycin-induced lung fibrosis.

Options: View larger image (or click on image) Download as PowerPoint
αTAT1 deficiency protects mice from bleomycin-induced lung fibrosis.
(A)...
(A) Schematic of the bleomycin-induced (BLM-induced) lung fibrosis model. Mice received a single intratracheal (i.t.) instillation of BLM (1.2 U/kg), and lungs were harvested 14 days later. (B) Immunofluorescence staining of lung sections from PBS- and BLM-treated mice showing increased α-tubulin K40 acetylation (Ac α-tubulin, red) in αSMA+ myofibroblasts (green). Nuclei: DAPI (blue). (n = 4 mice per group.) Scale bar: 100 μm. (C) Immunoblot analysis of α-tubulin K40 acetylation in fibroblasts isolated from fibrotic versus control mouse lungs. GAPDH, loading control. (n = 3 mice per group.) (D) Schematic of lung fibroblast isolation from wild-type (WT; Atat1+/+) and Atat1-deficient (Atat1–/–) mice. (E) Western blot showing loss of α-tubulin K40 acetylation in Atat1–/– fibroblasts compared with controls (n = 4 per group). (F) Quantification of fibroblast durotaxis on stiffness-gradient hydrogels, showing impaired directional migration in Atat1–/– cells (n = 3 mice per group.) (G) Representative Masson’s trichrome–stained lung sections from Atat1+/+ and Atat1–/– mice after PBS or BLM challenge, showing reduced collagen deposition in Atat1–/– lungs (n = 6 mice per group). Scale bar: 100 μm. (H) Quantification of lung collagen content by hydroxyproline (n = 6 mice per group). (I) Bronchoalveolar lavage (BAL) fluid protein concentration (n = 6 mice per group). (J) Flow cytometric quantification of immune cells in BAL at day 7 (n = 4 mice per group). (K) Immunofluorescence staining showing reduced αSMA+ myofibroblast accumulation (green) in BLM-treated Atat1–/– mice compared with Atat1+/+ controls. Nuclei: DAPI (blue). (n = 4 mice per group.) Scale bar: 100 μm. (L) Quantification of αSMA+ myofibroblasts per field (n = 4 mice per group). Data are presented as mean ± SD. For animal experiments, statistical significance was determined by 1-way ANOVA followed by Šidák’s multiple-comparison test. ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts